DK160981C - Arylsulfonylurinstof-derivater, fremgangsmaade til fremstilling deraf, anvendelse af disse som terapeutisk og antineoplastisk middel samt farmaceutiske midler indeholdende saadanne derivater - Google Patents

Arylsulfonylurinstof-derivater, fremgangsmaade til fremstilling deraf, anvendelse af disse som terapeutisk og antineoplastisk middel samt farmaceutiske midler indeholdende saadanne derivater

Info

Publication number
DK160981C
DK160981C DK446986A DK446986A DK160981C DK 160981 C DK160981 C DK 160981C DK 446986 A DK446986 A DK 446986A DK 446986 A DK446986 A DK 446986A DK 160981 C DK160981 C DK 160981C
Authority
DK
Denmark
Prior art keywords
derivatives
arylsulphonylurine
therapeutic
procedures
production
Prior art date
Application number
DK446986A
Other languages
English (en)
Other versions
DK446986D0 (da
DK446986A (da
DK160981B (da
Inventor
James Jeffry Howbert
Gerald Auston Poore
Brent Jeffrey Rieder
Richard Waltz Harper
Eddie Vi-Ping Tao
James Abraham Aikins
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK446986D0 publication Critical patent/DK446986D0/da
Publication of DK446986A publication Critical patent/DK446986A/da
Publication of DK160981B publication Critical patent/DK160981B/da
Application granted granted Critical
Publication of DK160981C publication Critical patent/DK160981C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK446986A 1985-09-23 1986-09-18 Arylsulfonylurinstof-derivater, fremgangsmaade til fremstilling deraf, anvendelse af disse som terapeutisk og antineoplastisk middel samt farmaceutiske midler indeholdende saadanne derivater DK160981C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US77935485A 1985-09-23 1985-09-23
US77935485 1985-09-23
US88867586A 1986-07-24 1986-07-24
US88867586 1986-07-24

Publications (4)

Publication Number Publication Date
DK446986D0 DK446986D0 (da) 1986-09-18
DK446986A DK446986A (da) 1987-03-24
DK160981B DK160981B (da) 1991-05-13
DK160981C true DK160981C (da) 1991-10-28

Family

ID=27119572

Family Applications (1)

Application Number Title Priority Date Filing Date
DK446986A DK160981C (da) 1985-09-23 1986-09-18 Arylsulfonylurinstof-derivater, fremgangsmaade til fremstilling deraf, anvendelse af disse som terapeutisk og antineoplastisk middel samt farmaceutiske midler indeholdende saadanne derivater

Country Status (21)

Country Link
EP (1) EP0222475B1 (da)
JP (1) JPH0662548B2 (da)
KR (1) KR880000204B1 (da)
CN (1) CN1013198B (da)
AU (1) AU587064B2 (da)
CY (1) CY1659A (da)
DE (1) DE3667168D1 (da)
DK (1) DK160981C (da)
EG (1) EG18046A (da)
ES (1) ES2001698A6 (da)
GR (1) GR862353B (da)
HK (1) HK88692A (da)
HU (1) HU200597B (da)
IE (1) IE59588B1 (da)
IL (1) IL80032A (da)
MX (1) MX9203126A (da)
NZ (1) NZ217597A (da)
PT (1) PT83389B (da)
SG (1) SG66892G (da)
SU (1) SU1545939A3 (da)
UA (1) UA5953A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845128A (en) * 1984-06-27 1989-07-04 Eli Lilly And Company N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides
CA1331464C (en) * 1987-05-12 1994-08-16 Eli Lilly And Company Anti-tumor method and compounds
HU202487B (en) * 1988-03-04 1991-03-28 Mta Koezponti Kemiai Kutato In Process for producing n-sulfonylureas
ZA915371B (en) * 1990-07-17 1993-03-31 Lilly Co Eli Antitumor compositions and methods of treatment
US5216026A (en) * 1990-07-17 1993-06-01 Eli Lilly And Company Antitumor compositions and methods of treatment
US5262440A (en) * 1991-12-10 1993-11-16 Eli Lilly And Company Antitumor compositions and methods of treatment
US5258406A (en) * 1991-12-20 1993-11-02 Eli Lilly And Company Sulfonimidamides
US5234955A (en) * 1991-12-20 1993-08-10 Eli Lilly And Company Antitumor compositions and methods of treatment
US5254582A (en) * 1992-02-05 1993-10-19 Eli Lilly And Company Antitumor compositions and methods
US5169860A (en) * 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment
US5270329A (en) * 1992-12-10 1993-12-14 Eli Lilly And Company Antitumor compositions and methods of treatment
CA2110524A1 (en) * 1992-12-10 1994-06-11 Gerald Burr Grindey Antitumor compositions and methods of treatment
ZA941500B (en) * 1993-03-10 1995-09-04 Lilly Co Eli Antitumor compositions and methods of treatment
US6063911A (en) * 1993-12-01 2000-05-16 Marine Polymer Technologies, Inc. Methods and compositions for treatment of cell proliferative disorders
DE69725794T9 (de) * 1996-08-07 2004-12-16 Tomita Pharmaceutical Co. Ltd., Naruto Granulat zur Abwasserbehandlung
CA2263353C (en) * 1996-08-22 2002-04-23 Dong Wha Pharm. Ind. Co., Ltd. Arylsulfonylimidazolone derivatives as an antitumor agent
ES2156550B1 (es) * 1999-04-19 2002-02-01 Univ Navarra Publica Derivados de benzo(b) tiofenosulfonamida-1,1-dioxido y su uso como agentes antineoplasicos.
JP5134247B2 (ja) * 2004-09-13 2013-01-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 スルホンアミド含有化合物の血管新生阻害物質との併用
WO2006030941A1 (ja) 2004-09-13 2006-03-23 Eisai R & D Management Co., Ltd. スルホンアミド含有化合物の血管新生阻害物質との併用
US8772269B2 (en) 2004-09-13 2014-07-08 Eisai R&D Management Co., Ltd. Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
KR20070114774A (ko) * 2005-02-28 2007-12-04 에자이 알앤드디 매니지먼트 가부시키가이샤 술폰아미드 화합물의 혈관 신생 저해 물질과의 신규 병용
WO2006090927A1 (ja) * 2005-02-28 2006-08-31 Eisai R & D Management Co., Ltd. スルホンアミド化合物の摂食亢進作用
PL1859793T3 (pl) * 2005-02-28 2011-09-30 Eisai R&D Man Co Ltd Nowe połączone zastosowanie związku sulfonamidowego w leczeniu choroby nowotworowej
EP2015070A4 (en) 2006-04-20 2010-04-21 Eisai R&D Man Co Ltd Novel marker for sensitivity against sulfonamide compound
JP2012136435A (ja) * 2009-03-30 2012-07-19 Eisai R & D Management Co Ltd 腫瘍組織の感受性を検査する方法
CN102993106B (zh) * 2012-12-24 2015-06-17 武汉武药制药有限公司 格列吡嗪的合成新路线
GB201618240D0 (en) * 2016-10-27 2016-12-14 Trade Vehicle Locks Ltd Apparatus for locking a door of a vehicle

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1144259B (de) * 1956-05-29 1963-02-28 Hoechst Ag Verfahren zur Herstellung von Sulfonylharnstoffen
US3097242A (en) * 1960-06-29 1963-07-09 Olin Mathieson Hydrindene sulfonylureas
DE1159937B (de) * 1960-06-29 1963-12-27 Heyden Chem Fab Verfahren zur Herstellung von Hydrindensulfonylharnstoffen
DE1240866B (de) * 1961-06-29 1967-05-24 Heyden Chem Fab Verfahren zur Herstellung von Indolin-6-sulfonylharnstoffen
US4634465A (en) * 1982-07-16 1987-01-06 Ciba-Geigy Corporation Fused N-phenylsulfonyl-N'-pyrimidinylureas and N-phenylsulfonyl-N'triazinylureas
IT1161220B (it) * 1983-04-21 1987-03-18 Montedison Spa Diidro-benzofurano derivati ad attivita' erbicida
US4845128A (en) * 1984-06-27 1989-07-04 Eli Lilly And Company N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides

Also Published As

Publication number Publication date
KR870003086A (ko) 1987-04-15
NZ217597A (en) 1989-06-28
IE59588B1 (en) 1994-03-09
ES2001698A6 (es) 1988-06-01
PT83389B (pt) 1989-05-12
CY1659A (en) 1993-05-14
CN86106428A (zh) 1987-03-18
KR880000204B1 (ko) 1988-03-12
JPH0662548B2 (ja) 1994-08-17
AU587064B2 (en) 1989-08-03
DK446986D0 (da) 1986-09-18
JPS6296459A (ja) 1987-05-02
IE862503L (en) 1987-03-23
UA5953A1 (uk) 1994-12-29
DE3667168D1 (de) 1990-01-04
EG18046A (en) 1991-08-30
PT83389A (en) 1986-10-01
HUT46657A (en) 1988-11-28
SG66892G (en) 1992-09-04
EP0222475A1 (en) 1987-05-20
HK88692A (en) 1992-11-20
AU6294286A (en) 1987-03-26
MX9203126A (es) 1992-07-01
SU1545939A3 (ru) 1990-02-23
IL80032A (en) 1992-07-15
DK446986A (da) 1987-03-24
HU200597B (en) 1990-07-28
CN1013198B (zh) 1991-07-17
EP0222475B1 (en) 1989-11-29
GR862353B (en) 1987-01-19
DK160981B (da) 1991-05-13

Similar Documents

Publication Publication Date Title
DK255086A (da) Heteroaromatiske aminderivater, laegemidler som indeholder disse forbindelser og fremgangsmaade til fremstilling af forbindelserne
DK393482A (da) Urinstofderivater, fremgangsmaade til fremstilling heraf og medikamenter indeholdende disse forbindelser samt deres anvendelse
DK213085A (da) Aminotetralinderivater, laegemidler indeholdende disse og fremgangsmaade til forbindelsernes fremstilling
DK163991C (da) Dichloranilinderivater, fremgangsmaade til fremstilling af disse, samt farmaceutiske praeparater indeholdende derivaterne
DK343388A (da) 2,2-dimethylchroman-3-ol-derivater og fremgangsmaade til fremstilling deraf, farmaceutiske midler indeholdende derivaterne samt disse anvendelse til fremstilling af farmaceutiske midler
DK167187D0 (da) Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
DK431586A (da) Benzimidazolderivater, fremgangsmaade til fremstilling deraf og laegemiddel indeholdende disse
DK219387D0 (da) Aminothiazol- og aminooxazolderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK518687D0 (da) Imidazo-benzoxazinoner, deres fremstilling og laegemidler indholdende forbindelserne
DK314887A (da) Kompleksforbindelser, farmaceutiske midler med indhold heraf samt fremgangsmaade til fremstilling heraf
DK408186D0 (da) Podophyllotoxin og derivater deraf, fremgangsmaader til deres fremstilling og anvendelse samt farmaceutiske praeparater indeholdende forbindelserne
DK162221C (da) Cinnolinforbindelser, fremgangsmaade til fremstilling deraf og farmaceutiske midler indeholdende forbindelserne
DK506386D0 (da) Flavonderivater, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
DK538885D0 (da) Imidazolylalkylguanidinderivater, fremgangsmaade til fremstilling herafsamt laegemidler indeholdende disse forbindelser
DK165951C (da) Imidazolderivater, fremgangsmaade til fremstilling heraf samt laegemidler indeholdende disse
NO863944D0 (no) L-dopa-derivater, fremgangsmaate til deres fremstilling og farmasoeytisk blanding inneholdende disse derivater.
DK102990D0 (da) Thieno-triazolodiazepinderivater, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
DK342187A (da) 4-pyridin-derivater, fremgangsmaade til fremstilling af saadanne derivater samt farmaceutiske praeparater indeholdende disse
DK612788A (da) Alkoxyderivater af ginkolider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende saadanne forbindelser
DK160816C (da) Benzoyl-urinstof-derivater, fremgangsmaade til fremstilling af disse, fremgangsmaade til bekaempelse af insektangreb samt insekticidt middel indeholdende disse
DK617684D0 (da) 1,3-dioxolanylderivater, fremgangsmaade til deres fremstilling, deres anvendelse og laegemidler indeholdende disse forbindelser
DK183886D0 (da) 4-phenylpropylindolderivater og deres salte og fremgangsmaade til deresfremstilling samt deres anvendelse som laegemidler
DK163512C (da) Substituerede azacyclohexylderivater af rifamyciner og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt en fremgangsmaade til fremstilling af forbindelserne
DK165789C (da) 4-oxo-4h-pyrimidooe2,1,aaaisoquinolinderivater, analogifremgangsmaade til fremstilling deraf, farmaceutisk praeparat indeholdende disse samt derivaterne til anvendelse som antiallergisk middel
DK507684A (da) Thiadiazinderivater, fremgangsmaader til deres fremstilling og farmaceutiske midler indeholdende disse thiadiazinderivater

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK